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Abstract
Background—Hemodynamic depression, including bradycardia and hypotension, is among the most
common complications of carotid angioplasty and stenting.
Methods and Material—A prospective, cross-sectional study was conducted at Shiraz University of
Medical Sciences in southern Iran from 2011 to 2013. Consecutive patients undergoing carotid angioplasty
and stenting were included. Demographic data, atherosclerotic risk factors, preprocedural blood pressure,
the site of stenosis, the degree of stenosis, and data regarding technical factors were recorded. Hemody-
namic depression was defined as a systolic blood pressure less than 90 mmHg and/or heart rate less than 50
beat/min.
Results—About 170 patients (67% male, mean age: 71+9.8, 55.9% right side, 82.9% symptomatic) were
recruited. Mean degree of stenosis was 79.4% in operated side and 40.7% in nonoperated side. Predilation,
postdilation, or both were conducted in 18(10.5%), 141(83%), 11(6.5%) patients respectively. Thirteen
(7.6%), 41(24%), and 12(7%) of patients developed postprocedural bradycardia, hypotension or both,
respectively. Two patients had a stroke after CAS and periprocedural mortality was 0%. Hemodynamic
depression after CAS had a significant association with preprocedure blood pressure and the use of an open
cell stent design, but not with atherosclerotic risk factors, site and/or degree of stenosis, predilation, or post-
dilation. Hemodynamic depression significantly increased hospital stay too.
Conclusion—Preprocedural hydration and close-cell stents may decrease the risk of poststenting hemo-
dynamic depression.
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Introduction
Stroke is one of the most common causes of mortality
and morbidity in both developed and developing coun-
tries [1]. Stenosis of the carotid bulb is the most com-
mon site of large artery atherosclerotic disease in
patients with ischemic stroke [2]. Carotid angioplasty
and stenting (CAS) is an emerging treatment option for
carotid stenosis [3]. The procedural steps, the use of pre-
and/or poststent angioplasty of the stenotic lesion in par-
ticular, vary from center to center.
Baroreceptors located in carotid sinuses are a crucial
part of the regulation of blood pressure and heart rate
[4]. The stretching of the carotid sinus caused by angio-
plasty and stenting can trigger the baroreceptors to trans-
mit signals to the brainstem, resulting in a transient
decrease in sympathetic tone and an increase in para-
sympathetic output. Bradycardia and hypotension may
result [5] that in turn may increase CAS complications
such as myocardial infarction and stroke[6].
We investigate the frequency and predictors of the
hemodynamic depression in patients undergoing CAS.
Methods and Materials
This is a prospective cross-sectional study conducted in
Kowsar and Alzahra hospitals affiliated with Shiraz Uni-
versity of Medical Sciences in Iran from 2011 to 2013.
These are high-volume referral centers for stroke in
southern Iran.
Consecutive patients with ischemic stroke documented
by a brain computed tomography (CT) or an magnetic
resonance imaging (MRI) were recruited. Patients
underwent noninvasive vascular and cardiac testing
along with laboratory studies to find the etiology of
ischemic stroke.
Patients with intracranial hemorrhage, cerebral infarcts
due to cardioaortic embolic causes, lacunar stroke, vas-
culitis, arterial dissection, and fibromuscular dysplasia
were excluded. Patients with Modified Rankin Scale
(MRS) more than four after stroke were excluded from
undergoing CAS. Patients who had relative contraindi-
cations of angiography were also excluded.
Major cerebrovascular risk factors were investigated for
all subjects. They included current, or previous cigarette
smoking, hyperlipidemia (positive history fasting total
cholesterol level >200 mg/dL, LDL>130 mg/dL, and/or
fasting triglycerides level>180 mg/dL), arterial hyper-
tension (positive history, systolic blood pressure >140
mmHg, and/or diastolic pressure>90 mmHg, out of the
acute phase, treated or not), and diabetes mellitus (posi-
tive history and/or fasting plasma glucose greater than
126 mg/dL out of the acute phase).
Patients with ischemic stroke and more than 70% steno-
sis of the ipsilateral internal carotid artery by noninva-
sive imaging underwent digital subtraction angiography
(DSA) as part of a preoperative evaluation for CAS. The
severity of stenosis was calculated according to the
North American symptomatic carotid endarterectomy
(NASCET) criteria [7]. Symptomatic patients with more
than 50% stenosis as documented by catheter angiogra-
phy and asymptomatic patients with more than 70%
were included.
Patients at high risk and standard risk of carotid endar-
terectomy were included.
All patients undergoing CAS received 80 mg of aspirin
and 75 mg of clopidogrel for at least 14 days before the
procedure or 600 mg loading dose of clopidogrel. After
the procedure, all patients were treated with 75 mg of
clopidogrel daily for 12 months and 80 mg of aspirin for
life. During the procedure, patients received heparin 80
U/kg after successful femoral artery puncture to main-
tain an activated clotting time (ACT) time more than
250.
Distal embolic protection devices (EPD) were crossed
the lesion and opened before predilation if possible. If
not usually with the stenotic segment was <1 mm, predi-
lation was performed before EPD insertion. Predilation
balloon diameters were 2.5 to 3 mm. If the diameter of
the stenotic segment was >3 mm, we deployed the EPD
without predilation.
In some patients, we did not use an EPD due to distal
tortuosity. A self-expanding stent was then placed across
the stenotic lesion. Stent diameters were 6 and 7 mm.
An open cell stent, the Protege® RX Carotid Stent(ev3
Endovascular, Inc., Plymouth, USA); a closed cell stent,
the Wallstent (Boston Scientific, Natick, USA); and a
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hybrid open and closed design stent, the Cristallo Ideale
(Invatec Technology, Frauenfeld,Switzerland) were used
in this study.
After stenting, an residual stenosis was measured by
angiography. The treatment was considered successful
when the residual stenosis was <50%. If the residual
stenosis was >50%, a balloon catheter was advanced for
postdilation. Postdilation balloon diameters were 5 to 6
mm. We tried not to perform multiple balloon dilatations
neither for pre- nor for postdilations .
Hemodynamic depression was defined as hypotension
and/or bradycardia. Hypotension was defined as systolic
blood pressure less than 90 mmHg or more than 30%
decrease in systolic blood pressure in comparison with
baseline recordings. Bradycardia was defined as heart
rate less than 50 beat/min.
Blood pressure and heart rate were measured from the
left arm by manometer and an automated electrocardio-
gram monitor, 10 minutes before, during and after the
procedure. Before pre- or postdilation atropine 1 mg
were intravenously administered to all patients regard-
less to their baseline heart rate.
When the bradycardia did not recover spontaneously,
additional atropine was administered. After the proce-
dure, the patients’ hemodynamics were closely moni-
tored for 24 hours or more. For persistent hypotension,
we first started a saline infusion. An intravenous infu-
sion of dopamine (3–10 μg/kg per minute) was used to
maintain the blood pressure if the saline infusion failed.
The baseline clinical data collected included age, gen-
der, and the presence of hypertension, hyperlipidemia,
diabetic mellitus, and smoking. We also recorded preop-
eration systolic and diastolic blood pressure, the site and
degree of stenosis on the operated and nonoperated
sides. Technical factors included in this study were pre-
dilation balloon length, diameter and maximal pressure,
stent type and size, postdilation balloon length, diameter
and maximal pressure if performed, maximal balloon
diameter, and maximal balloon length.
All patients provided written informed consent. The
study protocol was approved by the institutional review
board (IRB) of Shiraz University of Medical Sciences.
(89-01-01-2614)
Statistical analyses were performed using the Statistical
Package for the Social Sciences version 16.0 (SPSS Inc.,
Chicago, IL, USA). Continuous data are presented as the
mean±standard deviation (SD), and categorical data are
presented as the count (percentage). The normality of
distribution of continuous variables was assessed by the
Shapiro–Wilk test, and then, the independent samples
Student’s t-test and Mann–Whitney U-test were used to
compare the mean scores of variables with normal or
abnormal distribution respectively. The chi-squared test
and Fisher’s exact test were performed to compare the
proportions of categorical data when appropriate. Subse-
quently, multivariate analysis using binary logistic
regression was performed on variables that were signifi-
cant (p < 0.05 or very close to it) in univariate analysis.
Results
One hundred and seventy patients were recruited. Of
these, 114 patients (67%) were male. The mean±SD of
age was 71±9.8 [Min = 43, Max = 93, 95%CI: (69.5–
72.5)]. 74.1%, 71.2%, 32.9%, and 11.8% of patients had
hypertension, hyperlipidemia, diabetic mellitus, and
smoking, respectively. All patients were treated elec-
tively. CAS was performed under conscious sedation in
all patients.
The site of carotid stenosis was 95(55.9%) in right side.
Mean degree of stenosis were 79.4±14.5 % on the oper-
ated side and 40.7±35.1 on the nonoperated side. Mean
preoperation systolic and diastolic blood pressure were
126±20 [95%CI: (121.6–130.3)] and 76.7±10.9 [95%CI:
(74.3–79)], respectively. A total of 141 patients (82.9%)
were symptomatic.
Predilation, postdilation and both were conducted in
18(10.5%), 141(83%), and 11(6.5%) patients. Mean
length and diameter of balloons for predilation
were14.7±1.9 mm and 2.7±1 mm, respectively.
Mean length and diameter of stents were 39.3±2.5 mm
and 6.9±0.1 mm, respectively. For tapered stents, the
diameter of proximal end was considered.
Mean length, diameter of balloons for postdilation were
20.1±1.9 mm and 5.1±0.3 mm, respectively. Deployed
Stents were the Crystallo in 61(35.9%) patients, Wall-
stent in 97(57.1%) patients and Protégé in 12(7%)
patients.
Of 170 patients in our study, 13(7.6%), 41(24%),
12(7%) patients developed postprocedural bradycardia,
hypotension or both. Postprocedural hypotension was
transient and treated with hydration in eight patients
(19.5%) and dopamine administration in 33 patients
(80.5%). Four patients developed cardiac asystole after
balloon dilation which reversed with an additional dose
of atropine. Electrical shock was not indicated for any of
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these patients. Two patients had a stroke after CAS.
There was no periprocedural mortality. Table 1 demon-
strates risk factors and outcomes in patients who devel-
oped hemodynamic instability in comparison with the
patients who did not.
The binary logistic regression was performed in the next
step. The model contained five independent variables
(hypertension, preoperative systolic and diastolic blood
pressures, stent type and duration of admission). The full
model containing all predictors was significant, X2(6) =
48.03, p < 0.001, indicating that the model was able to
distinguish between the patients who developed hemo-
dynamic depression after stenting and who did not. The
model as a whole explained between 37.6% (Cox and
Snell R square) and 53.9% (Nagelkerke R square). The
model revealed that, of five mentioned variables, preop-
erative diastolic blood pressure (p < 0.001, OR = 0.86),
duration of admission (p = 0.001, OR = 14.5), and
hypertension (p = 0.04, OR = 0.26) made a significant
contribution to the model.
Discussion
The current study shows that hemodynamic depression
after CAS was significantly associated with preproce-
dure low blood and open cell stent design. Hemody-
namic depression significantly increased hospital length
of stay. There was numerically more hemodynamic
depression associated with postdilation and greater
length and diameters of postdilation balloons; however,
this association did not reach statistical significance.
The frequencies of post-CAS bradycardia and hypoten-
sion in the current series were 7.6% and 24%, respec-
tively. These frequencies ranged between 5%–76% and
14%–28%, respectively in previous series [8–13].
In a meta-analysis of 4,204 patients who underwent
CAS by Mylonas et al [5], hypotension, bradycardia or
both were seen in 39.4%, 12.1%, and 12.2% of patients,
respectively. The pooled estimate for persistent hemody-
namic depression was 19.2% [5]. Our rate of HD is
comparatively low. Preemptive administration of atro-
pine before ballooning may contribute in this.
In the current study, HD was not associated with
increased risk of MI and stroke but was associated with
increased hospital stay. HD may have negative effects
on CAS outcome. HD is associated with a greater risk of
postprocedural MI and mortality rate [14] in some previ-
ous studies, but these results were not reproduced in the
meta-analysis by Mylonas [5]. Meanwhile, it has been
shown that patients with HD after CAS have signifi-
cantly more DWI lesions than those without[15].
Table 1. Risk factors and outcomes of patients who underwent carotid angioplasty and stenting with and
without hemodynamic depression.
Variables
 
All patients (n = 170)
 
Patients who developed
hemodynamic depression
after stenting (n = 41)
 
Patients who did not develop
hemodynamic depression after
stenting (n = 129)
 
P-value*
 
Age (mean ± SD) 71±9.8 71.1±10.7 71±9.5 0.7
Male gender (%) 114(67%) 29(71%) 85(66%) 0.5
Diabetes mellitus (%) 56(33%) 15(37%) 41(32%) 0.5
Hypertension (%) 126(74%) 26(63%) 100(78%) 0.07
Hyperlipidemia (%) 121(71%) 31(76%) 90(70%) 0.4
Smoking (%) 20(12%) 6(15%) 14(11%) 0.5
Site of stenting:
Right side (%)
Left Side (%)
95(56%)
75(44%)
27(66%)
14(34%)
68(53%)
61(47%)
0.3
Stenosis in operated side (mean ± SD) 79.4±14.5 82.6±12.7 78.4±14.8 0.1
Stenosis in nonoperated side (mean ± SD) 40.7±35.1 38.8±36.3 41.3±35 0.5
Residual stenosis (mean ± SD) 11.3±13 12.6±12.5 10.8±13.3 0.1
Preprocedure SBP(mean ± SD)/DBP (mean ±
SD)
126±20/76.7±10.9 112.2±19.4/67±10.4 131.1±17.7/80.3±8.6 0.001/0.001
Stent Type
Closed cell (%)
Open cell (%)
Mixed type (%)
97(57%)
12(7%)
61(36%)
21(51%)
8(19.5%)
12(29%)
76(59%)
4(3%)
49(38%)
0.002
Predilatation (%) 29(17 %) 8(19.5%) 21(16%) 0.6
Postdilatation (%) 152(89%) 39(95%) 113(88%) 0.1
Stent length(mean + SD) 39.3±2.5mm 38.9±3.1mm 39.5±2.3mm 0.2
Stent diameter (mean ± SD) 6.9±0.1 mm 7±0.1mm 7±0.1mm 0.3
Myocardial infarction (%) 0(0%) 0(0%) 0(0%) --
Stroke (%) 2(1%) 0(0%) 2(1.5%) 1.00
Death (%) 0(0%) 0(0%) 0(0%) --
Duration of admission in days (mean ± SD)
 
2±0.3
 
2.1±0.5
 
2±0.2
 
0.04
 
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure.
*Significant P-values are bolded and demonstrate statistical difference between patients who develop hypotension after stenting and patients who did not.
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However, our study confirms that HD increases hospital
stay as has been seen in previous studies.
In the current study, 79.4% of patients underwent bal-
loon dilatation after stenting. Postdilation was not signif-
icantly associated with increased risk of hemodynamic
instability.
Some endovascular surgeons prefer to perform carotid
stenting without postdilation[16,17]. Qazi et al found
postdilation was associated with hemodynamic depres-
sion[18]. Others advocate for postdilation, arguing that it
increases flow to brain, decreasing hemodynamic
strokes and in addition provides a smoother surface and
reduces the risk of artery to artery embolization. In a ser-
ies by Baldi et al [16], 5.4% of the patients needed
another procedure due to lack of stent expansion [16].
In previous studies, age [5,19] degree of stenosis [8,20],
plaque calcification [8], plaque diameter [20], and
increased balloon pressure[8], history of coronary artery
disease[19], and hypertension before CAS were associ-
ated with HD [21].
We did not see protective effects of DM and smoking for
HD which has been seen in some previous studies. This
protective effect is thought to result from the impairment
of baroreceptors in diabetic autonomic neuropathy and
increased sympathetic tone by long-term smoking [9].
As dopamine and fluid therapy was immediately started
for nearly all patients who develop HD, we did not
encounter any MI or stroke in hemodynamically unsta-
ble patients. The efficacy of dopamine has been previ-
ously shown in similar patients[22].
The current study focused on technical and procedural
variables and their association with HD. We did not
investigate the significance of plaque characteristics [23]
and pretreatment drugs [14] that have been studied
before. This represents one study limitation. As all
patients were treated under conscious sedation, a com-
parison of conscious sedation versus general anesthesia
was impossible in current study. The low rate of death
and disability limits binary logistic regression and
increases the chance of type-II error.
In conclusion, we studied the frequency of HD in
patients undergoing carotid angioplasty and stenting in a
high-volume single-center recruiting both high risk and
standard risk. Although we routinely perform postdila-
tion, our rate of HD was not higher than previous stud-
ies. As HD was associated with procedural hypotension
and high radial force open-cell stents, Preemptive hydra-
tion and closed-cell stents are advocated.
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